CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Anhui Fengyuan Pharmaceutical Company Snapshot
Anhui Fengyuan Pharmaceutical operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Fengyuan Pharmaceutical with three other companies in this sector in China: Mayinglong Pharmaceutical Group Co Ltd (2016 sales of 2.10 billion Chinese Renmimbi [US$319.06 million] of which 48% was Pharmaceutical Circulation), SSY Group Ltd (2.02 billion Chinese Renmimbi [US$307.16 million] of which 94% was Intravenous Infusion Solution and Others), and Hengkang Medical Group Co Ltd (2.18 billion Chinese Renmimbi [US$330.07 million] of which 57% was Service).

Sales Analysis. During the year ended December of 2016, sales at Anhui Fengyuan Pharmaceutical were 2.03 billion Chinese Renmimbi (US$308.58 million). This is an increase of 30.9% versus 2015, when the company's sales were 1.55 billion Chinese Renmimbi. Sales of Medicine Retail Circulation saw an increase of 38.9% in 2016, from 920.20 million Chinese Renmimbi to 1.28 billion Chinese Renmimbi. Not all segments of Anhui Fengyuan Pharmaceutical experienced an increase in sales in 2016: sales of Other Operations fell 4.8% to 36.72 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Anhui Fengyuan Pharmaceutical
  Stock Performance Chart for Anhui Fengyuan Pharmaceutical
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 10.40
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 0.5%  
4 Weeks 3.7%   52 Weeks -10.8%  
 
Anhui Fengyuan Pharmaceutical Key Data:
  Ticker: 000153 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,033,461,344
(Year Ending Jan 2017).
Employees: 4,593
  Currency: Chinese Renmimbi Market Cap: 3,246,268,792
  Fiscal Yr Ends: December Shares Outstanding: 312,141,230
  Share Type: A Gu Closely Held Shares: 107,048,673
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.